Showing posts with label PandT committee. Show all posts
Showing posts with label PandT committee. Show all posts

Tuesday, April 22, 2014

Using a Lifeline: Drug Information

Posted by Adam Loyson at Tuesday, April 22, 2014

With the end of the semester approaching, final exams on the horizon, and commencements just around the corner, I write to you about my exciting tour on rotation with drug information (DI).  On this second to last rotation, I made sure to put in extra effort and learn as much knowledge as possible before my chapter as a student pharmacist later comes to a close.  I also continued to grow my skills in conducting systematic searches for information and providing clear and concise evidence-based answers to a variety of healthcare professionals.  Routine day on rotation you say?  Definitely not!  There were so many more opportunities to get involved while working in DI, some of the most rewarding I elucidate on below. 

The Basics
Today, there is an abundant amount of health information on the internet with much of it sketchy at best.  DI services, therefore, are a valuable resource to provide accurate and quality information in a timely manner.  The Drug Information Service I worked with while on rotation was responsible for servicing a tertiary healthcare center comprised of an adult hospital, a children’s hospital, 120 outpatient clinics, and 40 health centers, comprising a total of over 900 patient beds.  In addition, the service also provided pharmacotherapy consultation services for practitioners in southeastern Michigan.  The DI call center’s volume was rated at approximately 1,800 questions annually.  While on rotation, I had the opportunity to explore and find answers to the most common questions (medication’s therapeutic use, pharmacokinetics, dosing, drug interactions, toxicity, pregnancy/lactation use, compatibility, shortage availability) to the more extraordinary inquiries (homeopathic use, tapering regimens, stability in refrigerator/freezer outages, compounding regulations).  To answer effectively, I participated in weekly topic discussions and evidence-based medicine assessments to review most helpful DI resources, including those found online.
Of the more interesting requests during rotation, I was tasked to find out more on the use of oseltamivir in national strategic stockpiles, specifically the proper emergency preparedness handling of expired medications.  As someone hoping to enter public health after graduation, this was right up my alley!  After contacting the Food and Drug Administration, Centers for Disease Control, and my state’s community health department, I discovered that select lots of oseltamivir may receive extensions to their expiration dating via FDA announcement in emergent times of natural disaster.  Another interesting request came from a transplant pharmacist wanting to know more about the bioavailability and safety profile of magnesium treatments complexed with protein.  Early studies demonstrate more patients tolerating this organic chemical identity as compared to magnesium oxide.  I also found that larger trials were currently being conducted by the manufacturer, who agreed to send my institution notice as soon as they were published.

More than just an Operator
While answering drug information requests was a primary responsibility, I also participated in numerous projects associated with the Pharmacy and Therapeutics (P&T) committee, ambulatory infusion formulary committee, the cancer pharmacy committee, and the product and vendor selection subcommittee within the health system.  As the opportunity presented, I completed a P&T drug monograph on a monoclonal antibody aimed at inducing remission for those with ulcerative colitis and Crohn’s disease.  I also completed several MedWatch reports detailing drug adverse events and wrote a newsletter article to be sent out to the entire health system outlining the new guidelines released by the US Public Health Service detailing HIV post-exposure prophylaxis in occupational healthcare providers.  Of high value to the health system, I concluded my rotation by finishing a medication use evaluation on intravenous immunoglobulin to ensure proper ordering and dispensing of this extremely expensive blood product to patients.

Fuel for the Future

DI was just the rotation I needed to boost my skill set and confidence.  I now task other healthcare providers and students to give me their best shot.  If I don’t know the answer, I’ll know where to find it.  With another rotation completed, I continue on my path to being a professional with newly learned integration and collaboration skills necessary to help in determining the most appropriate course of action in a given healthcare situation.

Tuesday, October 25, 2011

It's Not Boring, I Swear.

Posted by Matthew Lewis at Tuesday, October 25, 2011

Hello Readers.

I'm already in the groove for my newest rotation, which is drug info. This is my second rotation in the Veteran's Affair group of hospitals, but there is a huge difference between the hospitals, and I think that is because of financial support. For example, the Detroit VA does not have a residency program but Ann Arbor (and Battle Creek) do.

[As a side note on residencies, several students from my class hope to be placed in the VA system, but I've been told that there aren't any residencies available at the Ann Arbor VA site this year. This situation isn't unique to VA as the demand for pharmacy residencies continues to outpace the supply
nationwide. That means increasingly intense competition for limited slots. Michigan has one of the highest pharmacy residency placement rates in the country, but being a Michigan PharmD does not automatically make you the preferred candidate for a residency. Landing a residency still comes down to polished interviewing skills and an ability to package your talents in ways that make you stand out from the crowd.]

Back to the story at hand. As I mentioned, my current rotation is drug info. My preceptor, Dr. Ed Lehaie is a great guy and was recognized as preceptor of the year for 1999. The first day was all about getting paperwork in and computer access. I even answered some questions. Today, I answered a few more questions, particularly on replacements for the pain medication fentanyl because there is a drug shortage looming on the horizon. First, I did not even realize there were other drugs in the fentanyl family, so learning about those was interesting. I compared onsets and found appropriate doses through literature searches for sufentanil, remifentanil, and alfentanil. Finally, I did a little cost analysis.

You may have heard about drug shortages in the news, since they have gotten so bad people are dying from not getting proper medications on time. Part of drug information's job is to figure out how to work around these shortages. The other major part of drug information's job is to ... well, dispense drug information. This is usually in the form of approving medication requests that are off-label or extremely costly, such as cancer medications. We will also present new drugs and new research to our pharmacy and therapeutics (P&T) committee, where they can discuss what additional restrictions they want to place on drugs. VA P&T committees are quite different from normal P&Ts, in that each hospital has to follow the nationally mandated formulary decided upon by the national P&T. The local hospitals can only further restrict use.

That's the nuts and bolts of this rotation. I'm definitely going to be getting some weird questions, so I'll keep in touch to share them all.